Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.

PubWeight™: 2.31‹?› | Rank: Top 2%

🔗 View Article (PMC 1944072)

Published in Br Med J on October 08, 1966

Authors

R H White, J S Cameron, J R Trounce

Articles citing this

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J (1969) 1.99

Cytotoxic drug therapy in steroid-resistant glomerulonephritis. Proc R Soc Med (1967) 1.42

Pharmacokinetics of cyclophosphamide in man. Br J Pharmacol (1971) 0.99

Paired trial of cyclophosphamide and prednisone in children with nephrosis. Arch Dis Child (1971) 0.89

Persistent proteinuria in children. Arch Dis Child (1969) 0.88

Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis. Arch Dis Child (1968) 0.87

Nephrotic syndrome due to primary renal disease in adults: II. A controlled trial of prednisolone and azathioprine. Br Med J (1969) 0.86

Effect of immunosuppression on chronic LCM virus infection of mice. J Exp Med (1973) 0.83

Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings. Can Med Assoc J (1968) 0.81

The mode of action of cytotoxic drugs. Proc R Soc Med (1970) 0.80

Treatment of the nephrotic syndrome. Br Med J (1970) 0.78

Cytotoxic agents in childhood glomerulonephritis. Arch Dis Child (1972) 0.78

Immunosupressive or anti-inflammatory? Br Med J (1967) 0.75

Steroid treatment in the nephrotic syndrome in childhood. Br Med J (1968) 0.75

Suppression of the immune response. J Med Genet (1971) 0.75

Management of the nephrotic syndrome due to primary renal disease. Can Med Assoc J (1967) 0.75

Antilymphocyte serum and glomerulonephritis. Br Med J (1970) 0.75

Mercaptopurine-dependent remission of nephrotic syndrome. Br Med J (1970) 0.75

Cyclophosphamide for nephrotic syndrome in children. Br Med J (1969) 0.75

Prognosis of the nephrotic syndrome. Br Med J (1968) 0.75

Management of the nephrotic syndrome. Arch Dis Child (1968) 0.75

Articles cited by this

Biopsy of kidney in prone position. Lancet (1954) 5.25

Estimation of eight serum proteins by a gel diffusion precipitin technique. J Lab Clin Med (1962) 4.99

The nephrotic syndrome. Diagnosis by renal biopsy and biochemical and immunological analyses related to the response to steroid therapy. Q J Med (1960) 4.33

THE BETA-1C GLOBULIN IN CHILDHOOD NEPHROTIC SYNDROME: LABORATORY DIAGNOSIS OF PROGRESSIVE GLOMERULONEPHRITIS. N Engl J Med (1965) 2.80

SELECTIVITY OF PROTEIN EXCRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME. J Clin Invest (1964) 2.56

The simple assessment of selectivity in heavy proteinuria. Lancet (1966) 2.36

164 children with nephrosis. Lancet (1961) 2.04

Cyclophosphamide in the treatment of systemic lupus erythematosus. Br Med J (1966) 1.83

The nephrotic syndrome in early infancy: a report of three cases. Arch Dis Child (1957) 1.48

CURRENT STUDIES ON THE EFFECT ANTIMETABOLITES IN NEPHROSIS, OTHER NON-NEOPLASTIC DISEASES, AND EXPERIMENTAL ANIMALS. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH. Ann Intern Med (1963) 1.41

IMMUNOSUPPRESSIVE AGENTS. Br Med Bull (1965) 1.38

IMMUNOLOGIC BASIS OF RENAL DISEASE. Pediatr Clin North Am (1964) 1.29

Mercaptopurine in the treatment of steroid-resistant nephrotic syndrome. N Engl J Med (1965) 1.23

EXPERIENCE WITH ALKYLATING AGENTS IN THE TREATMENT OF CHILDREN WITH THE NEPHROTIC SYNDROME. Med J Aust (1963) 1.22

ACUTE ANURIC GLOMERULONEPHRITIS. Q J Med (1964) 1.22

The nephrotic syndrome in children. I. Clinical response to nitrogen mustard therapy. J Pediatr (1952) 1.19

Current management of nephrosis statistical evaluation and a proposed approach to therapy. Pediatrics (1959) 1.16

The clinical significance of glomerular permeability studies. Proc R Soc Med (1966) 1.05

Essential hypertension in infancy and childhood; differential diagnosis and therapy. AMA J Dis Child (1956) 1.04

THIOGUANINE IN THE TREATMENT OF CERTAIN AUTOIMMUNE, IMMUNOLOGIC AND RELATED DISEASES. Am J Med (1964) 1.03

Therapy of the nephrotic syndrome: sodium restriction, dextran, and corticotropin (ACTH) alone or combined with nitrogen mustard. AMA Am J Dis Child (1955) 1.03

Treatment of the nephrotic syndrome with nitrogen mustard. J Lab Clin Med (1950) 1.02

NEPHROTIC SYNDROME. A CLINICAL AND PATHOLICAL STUDY. Arch Intern Med (1963) 0.97

[Clearance of specific blood protein fractions in patients with kidney disease]. Klin Wochenschr (1965) 0.97

Observations on percutaneous renal biopsy in children. Arch Dis Child (1963) 0.97

[IMMUNOSUPPRESSIVE CHEMOTHERAPY OF NEPHROTIC SYNDROMES AND CERTAIN TYPES OF GLOMERULONEPHRITIS]. Bull Acad Natl Med (1965) 0.87

[Trial treatment of various glomerular nephropathies with nitrogen mustards]. Sem Hop Ther Paris (1962) 0.87

Leukocytosis during steroid therapy. Am J Dis Child (1966) 0.87

Use of combined hormone and mechlorethamine (nitrogen mustard) therapy in lipoid nephrosis. AMA J Dis Child (1958) 0.87

The management of childhood nephrosis. Am Heart J (1965) 0.81

[TREATMENT OF NEPHROTIC SYNDROMES IN ADULT AFRICANS WITH CYCLOPHOSPHAMIDE]. Therapie (1964) 0.81

Articles by these authors

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med (1993) 4.03

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med (1996) 3.79

Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet (1970) 3.78

Cysteine desulfurase activity indicates a role for NIFS in metallocluster biosynthesis. Proc Natl Acad Sci U S A (1993) 3.59

Clinicopathological study of nephrotic syndrome in childhood. Lancet (1970) 3.13

Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. QJM (2002) 3.09

Urine microscopy as an aid to detection of bacteriuria. Lancet (1975) 3.09

Successful treatment of middle aged and elderly patients with end stage renal disease. Br Med J (Clin Res Ed) (1983) 2.88

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group. Ann Intern Med (1993) 2.74

Schönlein-Henoch nephritis. Q J Med (1972) 2.64

Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol (1972) 2.60

Management of urinary tract infection. Arch Dis Child (1987) 2.57

10 years' experience with regular haemodialysis and renal transplantation. Arch Dis Child (1980) 2.56

Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) (1986) 2.47

Management and dosing of warfarin therapy. Am J Med (2000) 2.36

The simple assessment of selectivity in heavy proteinuria. Lancet (1966) 2.36

Why the persistently high mortality in acute renal failure. Lancet (1972) 2.32

Prognosis of Henoch-Schönlein nephritis in children. Br Med J (1977) 2.32

Mechanism for the desulfurization of L-cysteine catalyzed by the nifS gene product. Biochemistry (1994) 2.26

Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J (1973) 2.07

Serum immune complexes and disease activity in lupus nephritis. Lancet (1977) 2.07

Prevalence of symptomless urinary tract disease in Birmingham schoolchildren. I. Pyuria and bacteriuria. Br Med J (1969) 2.01

Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J (1969) 1.99

Immunological aspects of candida infection complicating steroid and immunosuppressive drug therapy. Lancet (1970) 1.96

Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med (1975) 1.81

Genetics of classic Alport's syndrome. Lancet (1988) 1.73

Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med (1983) 1.70

Occurrence of S-methyl thioesters in urines of humans after they have eaten asparagus. Science (1975) 1.69

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial. Ann Intern Med (1991) 1.68

Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol (1974) 1.67

Clinical significance of antenatal calyceal dilatation detected by ultrasound. Lancet (1990) 1.64

Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis. Lancet (1974) 1.62

Selective pharmacological inhibition of lymphocyte stimulation. Lancet (1971) 1.62

Symptomless haematuria in childhood. Br Med J (1970) 1.61

Children referred for acute dialysis. Arch Dis Child (1971) 1.58

Stable isotope studies on the biosynthesis of lipoic acid in Escherichia coli. Biochemistry (1980) 1.56

Absorption of propranolol and practolol in Coeliac disease. Gut (1976) 1.55

The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol (1984) 1.55

The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost (2008) 1.55

Plasma C3 and C4 concentrations in management of glomerulonephritis. Br Med J (1973) 1.53

Quartan malarial nephrotic syndrome. Collaborative clinicopathological study in Nigerian children. Lancet (1972) 1.52

Long-term outcome for children with minimal-change nephrotic syndrome. Lancet (1985) 1.52

Renal biopsy diagnosis in children presenting with haematuria. Pediatr Nephrol (1998) 1.49

Coexistence of thin membrane and alport nephropathies in families with haematuria. Pediatr Nephrol (1999) 1.48

Broadcast television for Doctors-a first evaluation. Br Med J (1966) 1.48

Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet (1992) 1.47

Identification of methyl coenzyme M as an intermediate in methanogenesis from acetate in Methanosarcina spp. J Bacteriol (1984) 1.47

Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service. Arch Intern Med (1994) 1.46

Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol (1990) 1.44

The identification of 2,8-dihydroxyadenine, a new component of urinary stones. Biochem J (1976) 1.43

Cytotoxic drug therapy in steroid-resistant glomerulonephritis. Proc R Soc Med (1967) 1.42

Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study. J Thromb Haemost (2011) 1.42

Steroid responsive nephrotic syndrome is more common in Asians. Arch Dis Child (1985) 1.41

Shoulder pain. West J Med (1982) 1.41

Membranoproliferative glomerulonephritis and persistent hypocomplementaemia. Br Med J (1970) 1.41

Renal scarring and vesicoureteric reflux. Arch Dis Child (1978) 1.41

A plea for standardized terminology within the haemolytic uraemic syndromes. Pediatr Nephrol (1991) 1.39

Histology, protein clearances, and response to treatment in the nephrotic syndrome. Br Med J (1968) 1.39

Percutaneous transluminal renal angioplasty in patients with renal failure. Q J Med (1993) 1.39

Occurrence of coenzyme F420 and its gamma-monoglutamyl derivative in nonmethanogenic archaebacteria. J Bacteriol (1986) 1.37

Intraglomerular T cells and monocytes in nephritis: study with monoclonal antibodies. Kidney Int (1987) 1.37

Simplified quantification of urinary protein excretion in children. Clin Nephrol (1988) 1.35

Treatment of end-stage renal failure due to diabetes in the United Kingdom, 1975-84. Lancet (1986) 1.34

High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial. Br Med J (Clin Res Ed) (1983) 1.34

Screening methods for covert bacteriuria in schoolgirls. Br Med J (1975) 1.31

IgA and glomerular disease. Clin Nephrol (1976) 1.31

7-Methylpterin and 7-methyllumizine: oxidative degradation products of 7-methyl-substituted pteridines in methanogenic bacteria. J Bacteriol (1985) 1.31

Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant (1991) 1.30

Urinary tract infection in children. Br Med J (1977) 1.30

Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing. J Gen Intern Med (1987) 1.30

Seasonal nephrotic syndrome. Description and immunological findings. Clin Allergy (1975) 1.29

Prognostic significance of proteinuria one year after onset of diarrhea-associated hemolytic-uremic syndrome. J Pediatr (1991) 1.29

Analysis of 100 children with severe and persistent hypertension. Arch Dis Child (1976) 1.28

Immune responses in uremia. Clin Nephrol (1974) 1.28

Clinical evaluation of a rosette inhibition test in renal allotransplantation. Br Med J (1971) 1.27

Stable isotope studies on the biosynthesis of the thiazole moiety of thiamin in Escherichia coli. Biochemistry (1978) 1.27

Relapsing polychondritis with crescentic glomerulonephritis. Br Med J (1978) 1.25

5-(p-aminophenyl)-1,2,3,4-tetrahydroxypentane, a structural component of the modified folate in Sulfolobus solfataricus. J Bacteriol (1992) 1.24

Rhodopsin of the larval mosquito. J Gen Physiol (1972) 1.23

Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int (1990) 1.22

Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography. Cancer Chemother Pharmacol (1978) 1.22

Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol (1976) 1.22

The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol (1978) 1.21

The Crithidia luciliae kinetoplast immunofluorescence test in systemic lupus erythematosus. Clin Exp Immunol (1976) 1.20

Coagulation and thromboembolic complications in the nephrotic syndrome. Adv Nephrol Necker Hosp (1984) 1.19

Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother (2000) 1.19

Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus--nerve biopsy and response to plasma exchange. J Neurol (1982) 1.19

Micturition symptoms and unstable bladder activity in girls with primary vesicoureteric reflux. Br J Urol (1982) 1.18

Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int (1986) 1.18

Regional service for acute and chronic dialysis of children. Lancet (1970) 1.18

Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol (1990) 1.18

Poststreptococcal glomerulonephritis in children: clinicopathological correlations and long-term prognosis. Pediatr Nephrol (1988) 1.18

Identification of an archaeal 2-hydroxy acid dehydrogenase catalyzing reactions involved in coenzyme biosynthesis in methanoarchaea. J Bacteriol (2000) 1.18